XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.3
Note 12 - Restatement
9 Months Ended
Sep. 30, 2022
Notes to Financial Statements  
Error Correction [Text Block]

12.

Restatement

 

During the preparation of its Form 10-K for the year ended December 31, 2022, management of the Company identified misstatements with respect to recognition of sales revenue and related cost of sales during each of the three month periods ended March 31, 2022, June 30, 2022 and September 30, 2022. Management identified vehicle sales transactions where sales revenue and related cost of sales were incorrectly recognized upon approval of customer purchase incentives by certain government-sponsored electric vehicle incentive programs. Management determined that such approval did not coincide with a transfer of control under ASC Topic 606, Revenue from Contracts with Customers, and that revenue should have been recognized upon delivery of the vehicles to the customer.

 

In addition, in an unrelated transaction, the Company reclassed $387,000 from Accrued liabilities to Notes payable, net. This reclassification had no impact on total current liabilities.

 

The Company has restated its Consolidated Balance Sheet as of September 30, 2022, and the related Consolidated Statement of Operations, Consolidated Statement of Stockholders’ Equity and Consolidated Statement of Cash Flows for the three month and nine month periods ended September 30, 2022 to correct the misstatements described above.

 

The following table summarizes the effects of the restatement as of September 30, 2022 and for the three month and nine month periods ended September 30, 2022. Corresponding changes were made in the Consolidated Statement of Stockholders’ Equity and Consolidated Statement of Cash Flows. The restatement had no net effect on the cash flows of the Company.

 

  

September 30, 2022

 

Consolidated Balance Sheet Information:

 

As Previously

Reported

  

As Restated

 

Accounts receivable

 $7,804,369  $3,384,936 

Inventory, net

  3,603,852   5,954,375 
Inventory deposits  4,812,439   4,855,049 

Total current assets

  21,589,819   19,563,519 

Total assets

  73,749,477   71,723,177 
Accrued liabilities  1,154,026   767,026 
Notes payable, net  27,444   414,444 

Accumulated deficit

  (11,535,272)  (13,561,572)

Total stockholders’ equity

  72,388,228   70,361,928 

Total liabilities and stockholders’ equity

  73,749,477   71,723,177 

 

  

Three Months Ended September 30, 2022

  

Nine Months Ended September 30, 2022

 

Consolidated Statement of Operations Information:

 

As Previously

Reported

  

As Restated

  

As Previously

Reported

  

As Restated

 

Sales

 $3,882,670  $1,029,280  $7,078,870  $2,625,090 

Cost of sales

  2,046,491   677,855   3,998,533   1,599,290 

Gross profit

  1,836,179   351,425   3,080,337   1,025,800 
General and administrative expenses  1,619,210   1,584,973   6,142,194   6,113,957 

Income (loss) from operations

  97,782   (1,352,735)  (3,438,774)  (5,465,074)

Income (loss) before income taxes

  126,749   (1,323,768)  (3,410,912)  (5,437,212)

Net income (loss)

 $126,749  $(1,323,768) $(3,410,912) $(5,437,212)

Net income (loss) per share – basic and diluted

 $0.01  $(0.09) $(0.23) $(0.36)